Works matching AU Sun Young Rha


Results: 193
    1
    2
    3
    4
    5
    6
    7
    8

    Impact of Histology on Clinical Outcomes of Pembrolizumab Monotherapy in Patients With Advanced or Metastatic Urothelial Carcinoma in the Phase 3 KEYNOTE-045 and KEYNOTE-361 Trials.

    Published in:
    Clinical Genitourinary Cancer, 2025, v. 23, n. 2, p. N.PAG, doi. 10.1016/j.clgc.2024.102273
    By:
    • Giannatempo, Patrizia;
    • Machiels, Jean-Pascal;
    • Sassa, Naoto;
    • Arranz, Jose Angel;
    • Fujii, Yasuhisa;
    • Su, Wen-Pin;
    • Keam, Bhumsuk;
    • Culine, Stéphane;
    • Shen, Ying-Chun;
    • Langa, José Muñoz;
    • Sarid, David;
    • Aarts, Maureen;
    • Calabrò, Fabio;
    • Rosenbaum, Eli;
    • Moreno, Blanca Homet;
    • Bavle, Abhishek;
    • Xu, Jin Z.;
    • Rha, Sun Young
    Publication type:
    Article
    9
    10
    11
    12
    13
    14
    15
    16
    17
    18
    19
    20
    21
    22
    23
    24

    Phase II study of oxaliplatin, irinotecan and S-1 therapy in patients with advanced gastric cancer: the Korean Cancer Study Group ST14-11.

    Published in:
    Gastric Cancer, 2018, v. 21, n. 5, p. 802, doi. 10.1007/s10120-018-0794-1
    By:
    • Kim, Hyeong Su;
    • Ryu, Min-Hee;
    • Zang, Dae Young;
    • Park, Sook Ryun;
    • Han, Boram;
    • Kang, Won Ki;
    • Rha, Sun Young;
    • Jung, Minkyu;
    • Kim, Jin-Soo;
    • Kang, Byung Woog;
    • Lee, Kyung-Hee;
    • Rho, Sang-Young;
    • Kim, Jung Han;
    • Kim, Kab Choong;
    • Cho, Ji Woong;
    • Choi, Dae Ro;
    • Lim, Hyun;
    • Kang, Ho Suk;
    • Soh, Jae Seung;
    • Kim, Min-Jeong
    Publication type:
    Article
    25
    26
    27
    28
    29
    30
    31
    32
    33

    Risk factors and model for predicting toxicity-related treatment discontinuation in patients with metastatic renal cell carcinoma treated with vascular endothelial growth factor-targeted therapy: Results from the International Metastatic Renal Cell Carcinoma Database Consortium.

    Published in:
    2016
    By:
    • Kaymakcalan, Marina D.;
    • Xie, Wanling;
    • Albiges, Laurence;
    • North, Scott A.;
    • Kollmannsberger, Christian K.;
    • Smoragiewicz, Martin;
    • Kroeger, Nils;
    • Wells, J. Connor;
    • Rha, Sun‐Young;
    • Lee, Jae Lyun;
    • McKay, Rana R.;
    • Fay, André P.;
    • De Velasco, Guillermo;
    • Heng, Daniel Y. C.;
    • Choueiri, Toni K.
    Publication type:
    journal article
    34

    Metastatic non-clear cell renal cell carcinoma treated with targeted therapy agents: Characterization of survival outcome and application of the International mRCC Database Consortium criteria.

    Published in:
    Cancer (0008543X), 2013, v. 119, n. 16, p. 2999, doi. 10.1002/cncr.28151
    By:
    • Kroeger, Nils;
    • Xie, Wanling;
    • Lee, Jae‐Lyn;
    • Bjarnason, Georg A.;
    • Knox, Jennifer J.;
    • MacKenzie, Mary J.;
    • Wood, Lori;
    • Srinivas, Sandy;
    • Vaishamayan, Ulka N.;
    • Rha, Sun‐Young;
    • Pal, Sumanta K.;
    • Yuasa, Takeshi;
    • Donskov, Frede;
    • Agarwal, Neeraj;
    • Kollmannsberger, Christian K.;
    • Tan, Min‐Han;
    • North, Scott A.;
    • Rini, Brian I.;
    • Choueiri, Toni K.;
    • Heng, Daniel Y.C.
    Publication type:
    Article
    35
    36
    37
    38
    39
    40

    Differences in the Efficacies of Pazopanib and Gemcitabine/Docetaxel as Second-Line Treatments for Metastatic Soft Tissue Sarcoma.

    Published in:
    Oncology, 2019, v. 96, n. 2, p. 59, doi. 10.1159/000492597
    By:
    • Kim, Jee Hung;
    • Park, Hyung Soon;
    • Heo, Su Jin;
    • Kim, Sang Kyum;
    • Han, Jung Woo;
    • Shin, Kyoo-Ho;
    • Kim, Seung Hyun;
    • Hur, Hyuk;
    • Kim, Kyung Sik;
    • Choi, Young Deuk;
    • Kim, Sunghoon;
    • Lee, Young Han;
    • Suh, Jin-Suck;
    • Ahn, Joong-Bae;
    • Chung, Hyun Cheol;
    • Noh, Sung Hoon;
    • Rha, Sun Young;
    • Kim, Hyo Song
    Publication type:
    Article
    41
    42
    43
    44
    45
    46
    47
    48
    49
    50